Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 4804 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1Sulfation of catecholamines and serotonin by SULT1A3 allozymes
Ahsan F. Bairam,Mohammed I. Rasool,Fatemah A. Alherz,Maryam S. Abunnaja,Amal A. El Daibani,Saud A. Gohal,Katsuhisa Kurogi,Yoichi Sakakibara,Masahito Suiko,Ming-Cheh Liu
Biochemical Pharmacology.2018;151()104
[DOI]
2Face recognition in schizophrenia disorder: A comprehensive review of behavioral, neuroimaging and neurophysiological studies
Catherine Bortolon,Delphine Capdevielle,Stéphane Raffard
Neuroscience & Biobehavioral Reviews.2015;53()79
[DOI]
3Face recognition in schizophrenia disorder: A comprehensive review of behavioral, neuroimaging and neurophysiological studies
Hebert Luis Hernández-Montiel,Juan Carlos Solís-S,Pablo-García Solís,Mónica López Hidalgo,Nancy Georgina Hernández Chan,Lorena Asucena García Noguez,Julián Valeriano Reyes López,Ana Gabriela Hernández Puga,Haydé Azeneth Vergara Castañeda,Lorena Méndez Villa,Nelly Angélica Morales Guerrero
Neuroscience & Biobehavioral Reviews.2017;53()85
[DOI]
4Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study
Parita Shah,Yusuke Iwata,Eric E. Brown,Julia Kim,Marcos Sanches,Hiroyoshi Takeuchi,Shinichiro Nakajima,Margaret Hahn,Gary Remington,Philip Gerretsen,Ariel Graff-Guerrero
European Archives of Psychiatry and Clinical Neuroscience.2019;53()85
[DOI]
5Association Between Polymorphisms in the Genes for Tumor Suppressor Protein p53 and its Regulator NAD(P)H: Quinone Oxidoreductase 1 (NQO1) and Schizophrenia in a Syrian Study Cohort
Bassam Lajin,Amal Alachkar,Roula Michati,Amir Alhaj Sakur
Archives of Medical Research.2013;44(2)121
[DOI]
6Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases
Mira Polajnar,Eva Žerovnik
Journal of Cellular and Molecular Medicine.2014;18(9)1705
[DOI]
7Connectome organization is related to longitudinal changes in general functioning, symptoms and IQ in chronic schizophrenia
G. Collin,J. de Nijs,H.E. Hulshoff Pol,W. Cahn,M.P. van den Heuvel
Schizophrenia Research.2016;173(3)166
[DOI]
8Connectome organization is related to longitudinal changes in general functioning, symptoms and IQ in chronic schizophrenia
Heike Tost,Maria Zangl,Andreas Meyer-Lindenberg
Schizophrenia Research.2013;173(3)175
[DOI]
9Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Masahiro Nitta,Taishiro Kishimoto,Norbert Müller,Mark Weiser,Michael Davidson,John M. Kane,Christoph U. Correll
Schizophrenia Bulletin.2013;39(6)1230
[DOI]
10Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Anna Dietrich-Muszalska
Schizophrenia Bulletin.2016;39(6)57
[DOI]
11Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Eduardo García-Laredo
Schizophrenia Bulletin.2018;39(6)57
[DOI]
12Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Srinivasan Venkatesan
Schizophrenia Bulletin.2019;39(6)1
[DOI]
13Risk factors in early and late onset schizophrenia
Laura Chen,Ajit Selvendra,Anne Stewart,David Castle
Comprehensive Psychiatry.2018;80(6)155
[DOI]
14Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine
Bruna Mara Machado Ribeiro,Marta Regina Santos do Carmo,Rosemayre Souza Freire,Nayrton Flávio Moura Rocha,Vládia Célia Moreira Borella,Antonio Teles de Menezes,Aline Santos Monte,Patrícia Xavier Lima Gomes,Francisca Cléa Florenço de Sousa,Mariana Lima Vale,David Freitas de Lucena,Clarissa Severino Gama,Danielle Macêdo
Schizophrenia Research.2013;151(1-3)12
[DOI]
15Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine
Darshika Nigam
Schizophrenia Research.2015;151(1-3)143
[DOI]
16The Role of the Subplate in Schizophrenia and Autism: A Systematic Review
Marta Serati,Giuseppe Delvecchio,Giulia Orsenigo,Gian Mario Mandolini,Matteo Lazzaretti,Elisa Scola,Fabio Triulzi,Paolo Brambilla
Neuroscience.2019;408(1-3)58
[DOI]
17arouser Reveals a Role for Synapse Number in the Regulation of Ethanol Sensitivity
Mark Eddison,Douglas J. Guarnieri,Ling Cheng,Che-Hsiung Liu,Kevin G. Moffat,Graeme Davis,Ulrike Heberlein
Neuron.2011;70(5)979
[DOI]
18Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study
Jing-Li Gan,Zheng-Xiang Cheng,Hui-Feng Duan,Jia-Ming Yang,Xi-Quan Zhu,Cun-You Gao
Psychiatry Research: Neuroimaging.2014;223(1)23
[DOI]
19Multiple retinal anomalies in schizophrenia
Selin A. Adams,Henry A. Nasrallah
Schizophrenia Research.2018;195(1)3
[DOI]
20Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled study
Philip D. Harvey,Hiroshi Nakamura,Mitsukuni Murasaki
Neuropsychopharmacology Reports.2019;39(3)173
[DOI]
21Dysbindin-1 Involvement in the Etiology of Schizophrenia
Haitao Wang,Jiangping Xu,Philip Lazarovici,Wenhua Zheng
International Journal of Molecular Sciences.2017;18(10)2044
[DOI]
22Hippocampal Volume Reduction in First-Episode and Chronic Schizophrenia
Fulvia Adriano,Carlo Caltagirone,Gianfranco Spalletta
The Neuroscientist.2012;18(2)180
[DOI]
23Estrogen: The necessary evil for human health, and ways to tame it
Seema Patel,Ahmad Homaei,Akondi Butchi Raju,Biswa Ranjan Meher
Biomedicine & Pharmacotherapy.2018;102(2)403
[DOI]
24Evidence for a magnocellular disadvantage in early-onset schizophrenic patients: A source analysis of the N80 visual-evoked component
D. Núñez,J. Rauch,K. Herwig,A. Rupp,M. Andermann,M. Weisbrod,F. Resch,R. Oelkers-Ax
Schizophrenia Research.2013;144(1-3)16
[DOI]
25Ilk atak psikoz hastalarinda nötrofil lenfosit oraninin degerlendirilmesi
Nalan Varsak,Memduha Aydin,Ibrahim Eren
Aile Hekimligi ve Palyatif Bakim.2016;1(3)65
[DOI]
26Localized vs. Systematic Neurodegeneration: A Paradigm Shift in Understanding Neurodegenerative Diseases
Armin Bayati,Taryn Berman
Frontiers in Systems Neuroscience.2017;11(3)65
[DOI]
27Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review
Seema Patel
The Journal of Steroid Biochemistry and Molecular Biology.2017;168(3)19
[DOI]
28Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
Seema Patel
The Journal of Steroid Biochemistry and Molecular Biology.2018;182(3)27
[DOI]
29A cognitive regulatory control model of schizophrenia
Brad Bowins
Brain Research Bulletin.2011;85(1-2)36
[DOI]
30Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia
S. Kilian,J. K. Burns,S. Seedat,L. Asmal,B. Chiliza,S. Du Plessis,M. R. Olivier,M. Kidd,R. Emsley,Brion Maher
PLOS ONE.2017;12(1)e0170178
[DOI]